Get App Open
In App
Open App
you are here:

Eris Lifesciences Ltd.

BSE: 540596 | NSE: ERIS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE406M01024 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Dec 06, 11:51
659.10 -0.60 (-0.09%)
Volume
AVERAGE VOLUME
5-Day
5,535
10-Day
4,113
30-Day
7,052
3,125
  • Prev. Close

    659.70

  • Open Price

    666.50

  • Bid Price (Qty.)

    658.00 (8)

  • Offer Price (Qty.)

    659.10 (1)

NSE Live

Dec 06, 11:51
658.65 -0.85 (-0.13%)
Volume
AVERAGE VOLUME
5-Day
38,085
10-Day
30,088
30-Day
34,296
8,071
  • Prev. Close

    659.50

  • Open Price

    658.25

  • Bid Price (Qty.)

    658.00 (5)

  • Offer Price (Qty.)

    658.65 (4)

Financials

2021 2020 2019 2018 2017
Nine Months Results of Eris Lifesciences (in Rs. Cr.) Dec '21 Dec '20 Dec '19 Dec '18 Dec '17  
Net Sales/Income from operations 916.65 835.97 777.68 686.52 566.53  
Other Operating Income 16.94 16.02 11.82 11.59 --  
Total Income From Operations 933.59 851.99 789.49 698.11 566.53  
EXPENDITURE  
Consumption of Raw Materials 87.56 77.34 52.86 46.64 34.56  
Purchase of Traded Goods 52.69 81.83 59.33 58.08 48.17  
Increase/Decrease in Stocks 9.50 -10.73 19.26 -2.72 -2.92  
Power & Fuel -- -- -- -- --  
Employees Cost 169.54 160.67 140.73 125.73 95.15  
Depreciation 36.39 27.50 31.92 21.55 14.02  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 231.92 219.58 234.96 198.64 147.85  
P/L Before Other Inc. , Int., Excpt. Items & Tax 345.99 295.79 250.44 250.19 229.70  
Other Income 19.94 7.25 15.53 20.90 20.02  
P/L Before Int., Excpt. Items & Tax 365.92 303.04 265.97 271.08 249.72  
Interest 2.01 0.58 1.59 18.41 2.71  
P/L Before Exceptional Items & Tax 363.91 302.46 264.38 252.67 247.01  
Exceptional Items -- -- -- -- --  
P/L Before Tax 363.91 302.46 264.38 252.67 247.01  
Tax 33.43 21.21 28.21 19.71 10.86  
P/L After Tax from Ordinary Activities 330.48 281.26 236.17 232.97 236.16  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 330.48 281.26 236.17 232.97 236.16  
Equity Share Capital 13.59 13.58 13.75 13.75 13.75  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 24.33 20.71 17.17 16.94 17.18  
Diluted EPS 24.32 20.69 17.15 16.93 17.18  
EPS After Extra Ordinary  
Basic EPS. 24.33 20.71 17.17 16.94 17.18  
Diluted EPS. 24.32 20.69 17.15 16.93 17.18  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
Source : Dion Global Solutions Limited

Results of Pharmaceuticals & Drugs Sector

No News.
No News.
No News.
No News.